FDA Approved: PONVORY — Supplemental Application (Janssen Pharmaceuticals, Inc)

View source ↗

Summary

The FDA approved Janssen's supplemental application for PONVORY (ponesimod), expanding its labeling. The indication relates to treatment of relapsing forms of m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• PONVORY (PONESIMOD)

Snippet

SUPPL AP for PONVORY (PONESIMOD)